Outcomes of linezolid, glycopeptides, and other regimens in ampicillin-resistant, vancomycin-susceptible and vancomycin-resistant enterococcal bacteremia in a resource-limited setting: stewardship implications

Yameena Noman Khan, Ali Mala, Rubab Murtaza, Irshad Batool, Azizullah Khan, Imtiaz Begum, Jamil Muqtadir, Abdul Rasheed, Sameeullah Bhatti

Open source

DOI
10.1007/s00210-026-05701-2
Published
2026-07-12
Container
Naunyn-Schmiedeberg's Archives of Pharmacology
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s00210-026-05701-2,
  title = {Outcomes of linezolid, glycopeptides, and other regimens in ampicillin-resistant, vancomycin-susceptible and vancomycin-resistant enterococcal bacteremia in a resource-limited setting: stewardship implications},
  author = {Yameena Noman Khan and Ali Mala and Rubab Murtaza and Irshad Batool and Azizullah Khan and Imtiaz Begum and Jamil Muqtadir and Abdul Rasheed and Sameeullah Bhatti},
  year = {2026},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  doi = {10.1007/s00210-026-05701-2},
  url = {https://doi.org/10.1007/s00210-026-05701-2}
}

RIS

TY  - JOUR
TI  - Outcomes of linezolid, glycopeptides, and other regimens in ampicillin-resistant, vancomycin-susceptible and vancomycin-resistant enterococcal bacteremia in a resource-limited setting: stewardship implications
AU  - Yameena Noman Khan
AU  - Ali Mala
AU  - Rubab Murtaza
AU  - Irshad Batool
AU  - Azizullah Khan
AU  - Imtiaz Begum
AU  - Jamil Muqtadir
AU  - Abdul Rasheed
AU  - Sameeullah Bhatti
PY  - 2026
JO  - Naunyn-Schmiedeberg's Archives of Pharmacology
DO  - 10.1007/s00210-026-05701-2
UR  - https://doi.org/10.1007/s00210-026-05701-2
ER  - 

APA

Khan, Y. N., Mala, A., Murtaza, R., Batool, I., Khan, A., Begum, I., Muqtadir, J., Rasheed, A., & Bhatti, S. (2026). Outcomes of linezolid, glycopeptides, and other regimens in ampicillin-resistant, vancomycin-susceptible and vancomycin-resistant enterococcal bacteremia in a resource-limited setting: stewardship implications. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-026-05701-2

Source records